Pricing Log in Create free account

Galectin Therapeutics Inc. (GALT) vs Turn Therapeutics Inc. (TTRX)

Galectin Therapeutics Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Galectin Therapeutics Inc. and Turn Therapeutics Inc. are of similar size ($374.2M and $345.3M). Across the 8 metrics below, Galectin Therapeutics Inc. leads on 4 and Turn Therapeutics Inc. on 4.

Valuation

Metric GALT TTRX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 458.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (11.91%) (2.74%) (33.15%)
Free cash flow yield (6.68%) (1.42%) (25.50%)

Profitability

Metric GALT TTRX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 21.69% (3,315.33%) (56.36%)
Return on assets (184.22%) (99.59%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GALT TTRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 36.84% (80.72%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GALT TTRX Biotechnology median
Debt to equity (0.76) 8.83 0.00
Current ratio 0.10 1.19 4.72
Net debt to EBITDA (5.79) 0.96 0.96

Dividend

Metric GALT TTRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GALT TTRX Biotechnology median
Market cap 374.15m 345.25m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack